Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by coalbeton Sep 18, 2017 2:02pm

142 Views

Post# 26709958

Strong buy.

TLT Technical Analysis
As on 15th Sep 2017 TLT Share Price closed @ 0.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.36 & Strong Buy for SHORT-TERM with Stoploss of 0.44 we also expect STOCK to react on FollowingIMPORTANT LEVELS.

TLT Target for September
1^st Target up-side	0.52
2^nd Target up-side	0.56
3^rd Target up-side	0.6
1^st Target down-side	0.4
2^nd Target down-side	0.36
3^rd Target down-side	0.32